Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists discuss the body of literature suggesting that ceramides are drivers — and not merely passengers — on the road to cardiovascular disease.
[Nature Reviews Cardiology]
6445218 ZBW7UH2U items 1 apa 0 default asc 1 160584 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-014c50544e311298c54a5e09664d5304%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZBW7UH2U%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Choi%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EChoi%2C%20R.%20H.%2C%20Tatum%2C%20S.%20M.%2C%20Symons%2C%20J.%20D.%2C%20Summers%2C%20S.%20A.%2C%20%26amp%3B%20Holland%2C%20W.%20L.%20%282021%29.%20Ceramides%20and%20other%20sphingolipids%20as%20drivers%20of%20cardiovascular%20disease.%20%3Ci%3ENature%20Reviews%20Cardiology%3C%5C%2Fi%3E%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00536-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00536-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DZBW7UH2U%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ceramides%20and%20other%20sphingolipids%20as%20drivers%20of%20cardiovascular%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%20Hee%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20M.%22%2C%22lastName%22%3A%22Tatum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20David%22%2C%22lastName%22%3A%22Symons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20A.%22%2C%22lastName%22%3A%22Summers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20L.%22%2C%22lastName%22%3A%22Holland%22%7D%5D%2C%22abstractNote%22%3A%22Increases%20in%20calorie%20consumption%20and%20sedentary%20lifestyles%20are%20fuelling%20a%20global%20pandemic%20of%20cardiometabolic%20diseases%2C%20including%20coronary%20artery%20disease%2C%20diabetes%20mellitus%2C%20cardiomyopathy%20and%20heart%20failure.%20These%20lifestyle%20factors%2C%20when%20combined%20with%20genetic%20predispositions%2C%20increase%20the%20levels%20of%20circulating%20lipids%2C%20which%20can%20accumulate%20in%20non-adipose%20tissues%2C%20including%20blood%20vessel%20walls%20and%20the%20heart.%20The%20metabolism%20of%20these%20lipids%20produces%20bioactive%20intermediates%20that%20disrupt%20cellular%20function%20and%20survival.%20A%20compelling%20body%20of%20evidence%20suggests%20that%20sphingolipids%2C%20such%20as%20ceramides%2C%20account%20for%20much%20of%20the%20tissue%20damage%20in%20these%20cardiometabolic%20diseases.%20In%20humans%2C%20serum%20ceramide%20levels%20are%20proving%20to%20be%20accurate%20biomarkers%20of%20adverse%20cardiovascular%20disease%20outcomes.%20In%20mice%20and%20rats%2C%20pharmacological%20inhibition%20or%20depletion%20of%20enzymes%20driving%20de%20novo%20ceramide%20synthesis%20prevents%20the%20development%20of%20diabetes%2C%20atherosclerosis%2C%20hypertension%20and%20heart%20failure.%20In%20cultured%20cells%20and%20isolated%20tissues%2C%20ceramides%20perturb%20mitochondrial%20function%2C%20block%20fuel%20usage%2C%20disrupt%20vasodilatation%20and%20promote%20apoptosis.%20In%20this%20Review%2C%20we%20discuss%20the%20body%20of%20literature%20suggesting%20that%20ceramides%20are%20drivers%20%5Cu2014%20and%20not%20merely%20passengers%20%5Cu2014%20on%20the%20road%20to%20cardiovascular%20disease.%20Moreover%2C%20we%20explore%20the%20feasibility%20of%20therapeutic%20strategies%20to%20lower%20ceramide%20levels%20to%20improve%20cardiovascular%20health.%22%2C%22date%22%3A%222021-03-26%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41569-021-00536-1%22%2C%22ISSN%22%3A%221759-5010%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41569-021-00536-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-26T22%3A01%3A59Z%22%7D%7D%5D%7D
Choi, R. H., Tatum, S. M., Symons, J. D., Summers, S. A., & Holland, W. L. (2021). Ceramides and other sphingolipids as drivers of cardiovascular disease. Nature Reviews Cardiology, 1–11. https://doi.org/10.1038/s41569-021-00536-1 Cite
